Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Shoulder Innovations, Inc. (SI : NYSE)

• Company Description    Shoulder Innovations Inc. is a commercial-stage medical technology focused on transforming the shoulder surgical care market. Shoulder Innovations Inc. is based in GRAND RAPIDS, Mich. Number of Employees: 75

• Price / Volume Information    Yesterday's Closing Price: $20.41 Daily Weekly Monthly 20 Day Moving Average: 130,980 shares Shares Outstanding: 20.74 (millions) Market Capitalization: $423.26 (millions) Beta: 52 Week High: $23.00 52 Week Low: $10.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.55% -6.25% 12 Week 59.58% 55.21% Year To Date 42.73% 31.17%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1535 STEELE AVENUE SW SUITE B - GRAND RAPIDS,MI 49507 USA ph: 616-294-1026 fax: - ir@shoulderinnovations.com None

• General Corporate Information    Officers Robert Ball - Chief Executive Officer and Executive Chairman Jeffrey Points - Chief Financial Officer Matthew Ahearn - Director Richard J. Buchholz - Director Paul Buckman - Director Peer Information Shoulder Innovations, Inc. (CHCR) Shoulder Innovations, Inc. (ESRX) Shoulder Innovations, Inc. (MYDP) Shoulder Innovations, Inc. (COR) Shoulder Innovations, Inc. (GBCS) Shoulder Innovations, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 82537J108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 20.74 Most Recent Split Date: (:1) Beta: Market Capitalization: $423.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.43 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.67 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.18 Price/Cash Flow: - Price / Sales: 7.85 EPS Growth vs. Year Ago Period: 99.21% vs. Previous Quarter: -7.89% Sales Growth vs. Year Ago Period: 64.90% vs. Previous Quarter: 15.90% ROE 06/30/26 - - 03/31/26 - -35.11 12/31/25 - -50.24 ROA 06/30/26 - - 03/31/26 - -20.58 12/31/25 - -24.84 Current Ratio 06/30/26 - - 03/31/26 - 11.81 12/31/25 - 11.07 Quick Ratio 06/30/26 - - 03/31/26 - 10.04 12/31/25 - 9.55 Operating Margin 06/30/26 - - 03/31/26 - -55.93 12/31/25 - -55.84 Net Margin 06/30/26 - - 03/31/26 - -81.78 12/31/25 - -85.29 Pre-Tax Margin 06/30/26 - - 03/31/26 - -81.78 12/31/25 - -85.29 Book Value 06/30/26 - - 03/31/26 - 6.42 12/31/25 - 6.83 Inventory Turnover 06/30/26 - - 03/31/26 - 0.63 12/31/25 - 0.77 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.11 12/31/25 - 0.11 Debt-to-Capital 06/30/26 - - 03/31/26 - 10.11 12/31/25 - 9.58

Powered by Zacks Investment Research ©